Furthermore, ORY1001 treatment protected against obesity-associated glucose intolerance in mice correlating with a regression of hypothalamic HMG20A expression, indicative of reactive astrogliosis attenuation with improved health status. This evidence concerns the gene HMG20A and obesity due to melanocortin 4 receptor deficiency.